The content on this site is intended for healthcare professionals only
Prof Richard Schilsky, Dr Andrew Epstein and Dr Francois Quenet comment on data, during a press conference at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, from the PRODIGE 7 trial.
This was a phase III randomised trial in which patients with stage IV non-metastatic colorectal cancer received surgical treatment with or without heated oxaliplatin chemotherapy.
For more on these results watch Dr Quenet present the data in the press conference here, watch Dr Quenets interview with ecancer here and read the news story here.
Rectal cancer
KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer
Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients
Adjuvant radiotherapy has no benefit following radical prostatectomy
Neoadjuvant cemiplimab shows favourable event-free, disease-free and overall survival rates in patients with resectable CSCC
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
OncoAlert Round Up for September 15-21, 2023
OncoAlert Round Up for August 25th - 31st, 2023
OncoAlert Round Up for August 4th - 10th, 2023
